Technology News and Research

RSS

Weight Watchers International fourth quarter revenues increase 1.7% to $407.9 million

Weight Watchers International, Inc. today announced its fiscal 2012 results for the fourth quarter and full year and provided full year fiscal 2013 earnings guidance.

14 Feb 2013

Mindfulness practitioners gain enhanced control over sensory cortical alpha rhythms

Why does training in mindfulness meditation help patients manage chronic pain and depression? In a newly published neurophysiological review, Brown University scientists propose that mindfulness practitioners gain enhanced control over sensory cortical alpha rhythms that help regulate how the brain processes and filters sensations, including pain, and memories such as depressive cognitions.

14 Feb 2013

DBS can lead to long-term improvement in patients with neuropathic pain

For many patients with difficult-to-treat neuropathic pain, deep brain stimulation (DBS) can lead to long-term improvement in pain scores and other outcomes, according to a study in the February issue of Neurosurgery, official journal of the Congress of Neurological Surgeons.

14 Feb 2013

HealthSaaS, iMPak announce white labeling agreement for their Connected Outcomes Platform

iMPak Health, a subsidiary of Meridian Health, today announced a white labeling agreement with HealthSaaS for their Connected Outcomes Platform. This agreement will enhance iMPak's device offerings by bringing patient data into the clinical workflow as an asset while reducing manual data entry and providing actionable information to healthcare providers.

13 Feb 2013

Antibody therapeutics targeting GPCRs to be developed by alliance between MorphoSys and Heptares

MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) and UK-based Heptares Therapeutics, the leading GPCR drug discovery and development company, have signed an agreement to discover novel antibody therapeutics targeting G protein-coupled receptors (GPCRs), which are membrane proteins involved in a broad range of biological processes and diseases.

13 Feb 2013

Setting the scene: Economy, sequestration at heart of Obama's address

His State Of The Union comments will likely highlight the different partisan views on how these automatic spending cuts, set to kick in March 1, could be minimized. Republicans continue to press for changes in entitlement programs, such as Medicare.

13 Feb 2013

LSR grades for medical device manufacturers and fabricators debuted by Dow Corning at MD&M West

Dow Corning, a global leader in silicones, silicon-based technology and innovation for the healthcare industry, is showcasing at MD&M West (Hall D, Booth# 1751) Dow Corning® QP1 liquid silicone rubber (LSR) grades that give medical device manufacturers and fabricators broader material choices for intricate devices and components.

13 Feb 2013

Big Pharma looks to Africa for next growth market as economies strengthen, disease burden shifts

"Not only is Africa's economic growth grabbing attention in boardrooms but the shifting nature of its disease burden is luring Big Pharma, as new opportunities open up for treating chronic diseases afflicting the middle classes, rather than just fire-fighting infection," Reuters reports.

13 Feb 2013

Auditory training with noise can work in hearing-impaired children

Children with hearing loss struggle to hear in noisy school classrooms, even with the help of hearing aids and other devices to amplify their teacher's voice. Training the brain to filter out background noise and thus understand spoken words could help the academic performance and quality of life for children who struggle to hear, but there's been little evidence that such noise training works in youngsters.

13 Feb 2013

Fluidigm fourth quarter product revenue increases 25% to $15.4 million

Fluidigm Corporation today announced its financial results for the fourth quarter and full year ended December 31, 2012.

13 Feb 2013

Congenital anomaly prevalence should spark ART policy change

Assisted reproductive technology may be associated with the increased proportion of multiple birth infants affected by congenital abnormalities since the 1980s, European research suggests.

12 Feb 2013

Metastatic renal cell carcinoma (mRCC) therapy: an interview with Charles A. Nicolette, Ph.D., CSO of Argos Therapeutics

Metastatic renal cell carcinoma is a devastating disease. There are roughly 20-25,000 new cases per year in the United States and it is increasing for some reason.

12 Feb 2013

As feds encourage health IT, analysts forecast big increase in telehealth

In an age of the Web, Wi-Fi and ever-present social media, so-called e-health lags far behind. But federal officials leading the multibillion effort to get doctors and hospitals to use health information technology are now reaching out to patients and families to help them become e-patients.

12 Feb 2013

Young adults with depression symptoms may benefit from computerized avatars

Young adults, in a period of transition, are often reluctant to seek treatment for mental health problems because of the stigma, inadequate insurance coverage and difficulty finding a mental health care provider.

12 Feb 2013

AB SCIEX releases new testing method for laboratories to detect DCD in dairy products

AB SCIEX today announced the release of a new testing method for laboratories to screen for and quantify dicyandiamide ‒ known as DCD ‒ in dairy products and other protein-rich foods.

12 Feb 2013

STD Med, Pavilion announce joint investment to launch Saphena Medical

Pavilion Medical Innovations L.L.C. of Norwell, MA and STD Med, Inc. of Stoughton, MA are pleased to announce a joint investment to launch Saphena Medical, Inc., a new cutting edge medical device company focused on Endoscopic Vein Harvesting technologies.

12 Feb 2013

Landauer reports revenue of $36.7 million for first quarter 2013

Landauer, Inc., a recognized leader in personal and environmental radiation measurement and monitoring, outsourced medical physics services and high quality medical consumable accessories, today reported financial results for its fiscal 2013 first quarter ended December 31, 2012.

11 Feb 2013

Individualized flu immune responses revealed by high-throughput sequencing

Researchers have shown that it is possible to create personalized, individual-specific measurements of the antibody repertoire in response to influenza vaccination using high-throughput DNA sequencing technology.

11 Feb 2013

Experts discuss hottest topics in Alzheimer's brain imaging at 7th HAI conference

At the 7th Human Amyloid Imaging conference held last month in Miami, Florida, 250 experts discussed the hottest topics in Alzheimer's disease brain imaging.

11 Feb 2013

UPC develops new system for electroporation of cell cultures

Researchers from the Polytechnic University of Catalonia have developed a technique that improves and cuts the cost of a technique called electroporation, which involves opening pores in cell membranes using an electric field to introduce substances like drugs and DNA. Current methods are aggressive and expensive whereas the new system manages to apply low voltage electroporation with a small printed circuit board, which costs less than a Euro per unit and does not damage cells.

11 Feb 2013

Technology News and Research

Weight Watchers International fourth quarter revenues increase 1.7% to $407.9 million

Mindfulness practitioners gain enhanced control over sensory cortical alpha rhythms

DBS can lead to long-term improvement in patients with neuropathic pain

HealthSaaS, iMPak announce white labeling agreement for their Connected Outcomes Platform

Antibody therapeutics targeting GPCRs to be developed by alliance between MorphoSys and Heptares

Setting the scene: Economy, sequestration at heart of Obama's address

LSR grades for medical device manufacturers and fabricators debuted by Dow Corning at MD&M West

Big Pharma looks to Africa for next growth market as economies strengthen, disease burden shifts

Auditory training with noise can work in hearing-impaired children

Fluidigm fourth quarter product revenue increases 25% to $15.4 million

Congenital anomaly prevalence should spark ART policy change

Metastatic renal cell carcinoma (mRCC) therapy: an interview with Charles A. Nicolette, Ph.D., CSO of Argos Therapeutics

As feds encourage health IT, analysts forecast big increase in telehealth

Young adults with depression symptoms may benefit from computerized avatars

AB SCIEX releases new testing method for laboratories to detect DCD in dairy products

STD Med, Pavilion announce joint investment to launch Saphena Medical

Landauer reports revenue of $36.7 million for first quarter 2013

Individualized flu immune responses revealed by high-throughput sequencing

Experts discuss hottest topics in Alzheimer's brain imaging at 7th HAI conference

UPC develops new system for electroporation of cell cultures

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News